What is the appropriate next step in work‑up for a 46‑year‑old man with left‑eye nasal hemianopia, inferior altitudinal scotoma, preserved visual acuity, probable relative afferent pupillary defect, optic‑disc pallor, and a normal MRI of the cranium and orbits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Proceed with comprehensive laboratory and serological workup for optic neuropathy, including inflammatory, infectious, and vascular etiologies

Given the clinical presentation of nasal hemianopia with inferior altitudinal scotoma, optic disc pallor, probable RAPD, and a non-contributory MRI, the next step is to pursue laboratory evaluation for non-compressive optic neuropathy causes, particularly ischemic optic neuropathy and inflammatory/demyelinating conditions.

Clinical Reasoning

The clinical picture suggests an optic nerve abnormality rather than a chiasmal or retinal process. The combination of:

  • Nasal hemianopia (unusual for typical chiasmal compression)
  • Inferior altitudinal scotoma (classic for anterior ischemic optic neuropathy)
  • Optic disc pallor (indicating chronic optic nerve damage)
  • Preserved visual acuity
  • Normal MRI cranium and orbits

This constellation points toward a non-compressive optic neuropathy, most likely ischemic in nature, though inflammatory and demyelinating causes must be excluded.

Why Additional Imaging is NOT the Next Step

While the ACR Appropriateness Criteria 1 recommend MRI orbits without and with IV contrast as the initial imaging for suspected optic nerve abnormalities, this patient has already had non-contributory MRI of cranium and orbits. The guidelines specify that MRI with contrast provides superior soft tissue resolution to identify disease involving the nerve and nerve sheath, with signal changes and enhancement characteristics permitting differentiation of pathologies 1. However, since this has been completed without findings, repeating imaging with contrast would only be indicated if there is high clinical suspicion for inflammatory optic neuropathy, demyelinating disease, or if symptoms progress 2.

Laboratory Workup Priority

The appropriate next steps include:

For Ischemic Optic Neuropathy (Most Likely)

  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) - to exclude giant cell arteritis, particularly critical in patients over 50
  • Complete blood count with differential
  • Comprehensive metabolic panel
  • Fasting lipid profile and hemoglobin A1c - vascular risk factors
  • Consider temporal artery biopsy if ESR/CRP elevated or high clinical suspicion

The inferior altitudinal scotoma with optic disc pallor is highly characteristic of anterior ischemic optic neuropathy (AION) 3, 4. Non-arteritic AION typically presents with acute, painless visual loss and is an exclusion diagnosis 4.

For Inflammatory/Demyelinating Causes

  • Antinuclear antibody (ANA)
  • Anti-neutrophil cytoplasmic antibodies (ANCA)
  • Angiotensin-converting enzyme (ACE) level - for sarcoidosis
  • Aquaporin-4 and MOG antibodies - for neuromyelitis optica spectrum disorder
  • Syphilis and Lyme serologies if risk factors present

Vascular Imaging Consideration

The ACR guidelines note that in cases of ischemic optic neuropathy, vascular imaging of the head and neck (MRA) may be subsequently performed to assess for vascular disease 1. This would be appropriate after laboratory workup if ischemic etiology is confirmed and embolic source is suspected.

Important Caveats

The nasal hemianopia component is atypical - while altitudinal defects respect the horizontal meridian in optic nerve pathology 3, a nasal hemianopic component could suggest:

  • Junctional involvement (optic nerve at chiasm junction) - though MRI was negative for compression 5, 6
  • Sequential or bilateral optic nerve pathology
  • Overlapping field defects from sectoral optic neuropathy

Optic disc pallor indicates chronicity - this suggests the acute event occurred weeks to months prior, and you may be evaluating residual damage. This makes inflammatory causes less likely unless there were recurrent episodes.

The "probable" RAPD requires confirmation - a definitive RAPD would strongly support unilateral or asymmetric bilateral optic nerve dysfunction 2.

When to Reconsider Imaging

MRI orbits with contrast should be reconsidered if 1:

  • Laboratory workup is unrevealing
  • Symptoms progress or new symptoms develop
  • Clinical suspicion for inflammatory optic neuropathy or demyelinating disease increases
  • There is concern for optic nerve sheath meningioma (though typically causes more gradual, progressive vision loss)

The combination of optic nerve enhancement pattern and distribution of white matter lesions can distinguish between AION and inflammatory optic neuritis with high accuracy 1.

Related Questions

What is the appropriate management for a 46-year-old man with a two‑month history of left‑eye visual‑field defect (nasal hemianopia and inferior altitudinal scotoma on perimetry), normal visual acuity, probable left relative afferent pupillary defect (RAPD) and optic‑disc pallor?
Is a visual field defect with nasal loss in the right eye and temporal loss in the left eye a heteronymous (bitemporal) defect, and what are the appropriate next diagnostic steps?
How do you describe a right eye nasal visual field defect combined with a left eye temporal visual field defect?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
In a patient with acute coronary syndrome and an elevated pro‑BNP but no signs of heart failure or acute congestion, should a sodium‑glucose cotransporter‑2 (SGLT‑2) inhibitor be initiated?
After taking bupropion sustained-release (150 mg daily) for 17 days and adding lisdexamfetamine (Vyvanse) 20 mg daily for 3 days, should I increase the lisdexamfetamine dose now to reduce persistent irritability, or adjust the regimen in another way?
In a healthy, slightly overweight 25-year-old patient presenting for a first primary-care visit with no complaints, which laboratory tests should be ordered?
Is clonazepam appropriate for treating tremor, and what dosing regimen should be used?
What class of medication is Procardia (verapamil)?
For a patient with a mildly displaced fifth metacarpal fracture whose radiographs were taken five days ago, should repeat radiographs be obtained today to assess alignment before applying a Donjoy ulnar‑gutter splint?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.